Defense Startup Picogrid Raises $12M to Connect Defense Systems
Founders
The core of Picogrid's technology lies in Legion, its cloud-based API used to connect and control various third-party autonomous systems. This includes drones, unmanned vehicles, and AI-driven surveillance tools, all working together in a cohesive and intelligent ecosystem. "Our platform is a paradigm shift in defense operations, offering unprecedented levels of coordination and real-time intelligence," says
Early customer signals are a sign of great things to come. Since its launch, Picogrid has won over a dozen federal contracts, including a
This funding is a pivotal step for Picogrid, allowing it to accelerate product development, ramp up manufacturing with the opening of its second factory in
For media inquiries, please contact: [email protected]
About Picogrid
Picogrid is a defense technology company that builds a unified platform for autonomous systems. The company's technology helps connect sensors, cameras, and unmanned systems with the software systems that increasingly depend on them. Based in
About Initialized Capital
Initialized Capital is an early-stage venture firm that invests with conviction before it's obvious. We're a diverse group of founders, builders, and operators who understand how hard it is to build a company. We back visionaries using software to make civilization better and support them through product-market fit and beyond. We're early believers in companies like Coinbase, Instacart, Flexport, and Cruise. Initialized's portfolio — which spans over six core funds — is worth close to
View original content to download multimedia:https://www.prnewswire.com/news-releases/defense-startup-picogrid-raises-12m-to-connect-defense-systems-302099219.html
SOURCE Picogrid
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- On the 12th Edition of Global Patient Week Bristol Myers Squibb and Saudi Schizophrenia Association 'Ehtiwaa' Collaborate to Support People Living with Schizophrenia Through the 'Small Wins' Initiativ
- Bybit Supports Stocks Trading, Giving Eligible Global Users Access to 1,000+ U.S. Stocks and ETFs
- Foresee Pharmaceuticals Announces China NMPA Approval of CAMCEVI® 42 mg for the Treatment of Advanced Prostate Cancer; Changchun GeneScience Pharmaceutical will Commercialize in China
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share